Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13909016 | 0.91 | CRHR1 (0.48) | CRHR1ERG | |
| SCHEMBL5847449 | 0.90 | CRHR1 (0.47) | CRHR1 | |
| SCHEMBL5847945 | 0.86 | CRHR1 (0.47) | CRHR1 | |
| SCHEMBL4032505 | 0.84 | CRHR1 (0.43) | CRHR1ERG | |
| SCHEMBL4038331 | 0.83 | CRHR1 (0.42) | CRHR1ERG | |
| SCHEMBL4034624 | 0.81 | MMP3 (0.39) | CRHR1 | |
| SCHEMBL13220708 | 0.81 | CRHR1 (0.68) | CRHR1ERG | |
| SCHEMBL3043494 | 0.81 | CRHR1 (0.68) | CRHR1ERG | |
| Hydrochloric Acid SCHEMBL4035323 | 0.80 | MMP3 (0.39) | CRHR1 | |
| Hydrochloric Acid SCHEMBL3041431 | 0.80 | CRHR1 (0.67) | CRHR1ERG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858809-B2 | Process for production of pyrazole-fused ring derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-12-28 | — | — | US | disclosed |
| US-7858809-B2 | Process for production of pyrazole-fused ring derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-12-28 | — | — | US | disclosed |
| US-7858809-B2 | Process for production of pyrazole-fused ring derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-12-28 | — | — | US | disclosed |
| EP-1555265-B1 | 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS | EISAI R&D MAN CO LTD (JP) | 2009-03-25 | — | — | EP | disclosed |
| EP-1555265-B1 | 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS | EISAI R&D MAN CO LTD (JP) | 2009-03-25 | — | — | EP | disclosed |
| US-20080076943-A1 | 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS | HIBI SHIGEKI | 2008-03-27 | — | — | US | disclosed |
| US-20080076943-A1 | 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS | HIBI SHIGEKI | 2008-03-27 | — | — | US | disclosed |
| US-20080076943-A1 | 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS | HIBI SHIGEKI | 2008-03-27 | — | — | US | disclosed |
| US-7323569-B2 | 7-phenylpyrazolopyridine compounds | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2008-01-29 | — | — | US | disclosed |
| US-7323569-B2 | 7-phenylpyrazolopyridine compounds | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2008-01-29 | — | — | US | disclosed |
| US-7323569-B2 | 7-phenylpyrazolopyridine compounds | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2008-01-29 | — | — | US | disclosed |
| US-20070191613-A1 | Process for production of pyrazole-fused ring derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070191613-A1 | Process for production of pyrazole-fused ring derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070191613-A1 | Process for production of pyrazole-fused ring derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
| US-7176216-B2 | 7-phenylpyrazolopyridine compounds | EISAI CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-7176216-B2 | 7-phenylpyrazolopyridine compounds | EISAI CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-7176216-B2 | 7-phenylpyrazolopyridine compounds | EISAI CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-20060235011-A1 | 7-Phenyl pyrazolopyridine compounds | EISAI CO.LTD. (JP) | 2006-10-19 | — | — | US | disclosed |
| EP-1555265-A1 | 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS | Eisai Co., Ltd. (JP) | 2005-07-20 | — | — | EP | disclosed |
| US-20040224974-A1 | 7-phenylpyrazolopyridine compounds | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2004-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040224974-A1 | 7-phenylpyrazolopyridine compounds | CRHR1, MC2R, CRH | CRHR1 1/4885ERG 1697/4885 |
| US-20080076943-A1 | 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS | MC2R, CRHR1, CRHR2 | CRHR1 2/4885ERG 1359/4885 |
| US-20060235011-A1 | 7-Phenyl pyrazolopyridine compounds | MC2R, CRHR1, CRHR2 | CRHR1 2/4885ERG 1393/4885 |
| US-20070191613-A1 | Process for production of pyrazole-fused ring derivatives | CYP4F3, CYP4F2, CYP2F1 | CRHR1 2190/4885ERG 1972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.